186 related articles for article (PubMed ID: 20927405)
1. A selection fit mechanism in BMP receptor IA as a possible source for BMP ligand-receptor promiscuity.
Harth S; Kotzsch A; Hu J; Sebald W; Mueller TD
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927405
[TBL] [Abstract][Full Text] [Related]
2. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
[TBL] [Abstract][Full Text] [Related]
3. The solution structure of BMPR-IA reveals a local disorder-to-order transition upon BMP-2 binding.
Klages J; Kotzsch A; Coles M; Sebald W; Nickel J; Müller T; Kessler H
Biochemistry; 2008 Nov; 47(46):11930-9. PubMed ID: 18937504
[TBL] [Abstract][Full Text] [Related]
4. Crystallization of BMP receptor type IA bound to the antibody Fab fragment AbD1556.
Harth S; Kotzsch A; Sebald W; Mueller TD
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Aug; 66(Pt 8):964-8. PubMed ID: 20693682
[TBL] [Abstract][Full Text] [Related]
5. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.
Nickel J; Dreyer MK; Kirsch T; Sebald W
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668
[TBL] [Abstract][Full Text] [Related]
6. Binding of integrin α1 to bone morphogenetic protein receptor IA suggests a novel role of integrin α1β1 in bone morphogenetic protein 2 signalling.
Zu Y; Liang X; Du J; Zhou S; Yang C
J Biomech; 2015 Nov; 48(14):3950-4. PubMed ID: 26475222
[TBL] [Abstract][Full Text] [Related]
7. Structure of the ternary signaling complex of a TGF-beta superfamily member.
Allendorph GP; Vale WW; Choe S
Proc Natl Acad Sci U S A; 2006 May; 103(20):7643-8. PubMed ID: 16672363
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity.
Kotzsch A; Nickel J; Seher A; Sebald W; Müller TD
EMBO J; 2009 Apr; 28(7):937-47. PubMed ID: 19229295
[TBL] [Abstract][Full Text] [Related]
9. A single residue of GDF-5 defines binding specificity to BMP receptor IB.
Nickel J; Kotzsch A; Sebald W; Mueller TD
J Mol Biol; 2005 Jun; 349(5):933-47. PubMed ID: 15890363
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
11. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.
Namiki M; Akiyama S; Katagiri T; Suzuki A; Ueno N; Yamaji N; Rosen V; Wozney JM; Suda T
J Biol Chem; 1997 Aug; 272(35):22046-52. PubMed ID: 9268344
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured hydroxyapatite surfaces-mediated adsorption alters recognition of BMP receptor IA and bioactivity of bone morphogenetic protein-2.
Huang B; Yuan Y; Ding S; Li J; Ren J; Feng B; Li T; Gu Y; Liu C
Acta Biomater; 2015 Nov; 27():275-285. PubMed ID: 26360594
[TBL] [Abstract][Full Text] [Related]
13. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
14. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.
Kirsch T; Nickel J; Sebald W
EMBO J; 2000 Jul; 19(13):3314-24. PubMed ID: 10880444
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions.
Singhatanadgit W; Salih V; Olsen I
J Cell Physiol; 2006 Dec; 209(3):912-22. PubMed ID: 17001689
[TBL] [Abstract][Full Text] [Related]
16. High-throughput measurements of bone morphogenetic protein/bone morphogenetic protein receptor interactions using biolayer interferometry.
Khodr V; Machillot P; Migliorini E; Reiser JB; Picart C
Biointerphases; 2021 Jun; 16(3):031001. PubMed ID: 34241280
[TBL] [Abstract][Full Text] [Related]
17. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.
Hatta T; Konishi H; Katoh E; Natsume T; Ueno N; Kobayashi Y; Yamazaki T
Biopolymers; 2000; 55(5):399-406. PubMed ID: 11241215
[TBL] [Abstract][Full Text] [Related]
18. Sulfated glycosaminoglycans exploit the conformational plasticity of bone morphogenetic protein-2 (BMP-2) and alter the interaction profile with its receptor.
Hintze V; Samsonov SA; Anselmi M; Moeller S; Becher J; Schnabelrauch M; Scharnweber D; Pisabarro MT
Biomacromolecules; 2014 Aug; 15(8):3083-92. PubMed ID: 25029480
[TBL] [Abstract][Full Text] [Related]
19. The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding.
Hauburger A; von Einem S; Schwaerzer GK; Buttstedt A; Zebisch M; Schräml M; Hortschansky P; Knaus P; Schwarz E
FEBS J; 2009 Nov; 276(21):6386-98. PubMed ID: 19804412
[TBL] [Abstract][Full Text] [Related]
20. Changes in bone morphogenetic protein receptor-IB localisation regulate osteogenic responses of human bone cells to bone morphogenetic protein-2.
Singhatanadgit W; Mordan N; Salih V; Olsen I
Int J Biochem Cell Biol; 2008; 40(12):2854-64. PubMed ID: 18619554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
